Advanced search
Publication Cover
International Journal of Nephrology and Renovascular Disease Volume 5, 2012 - Issue
Submit an article Journal homepage
65
Views
27
CrossRef citations to date
0
Altmetric
Case Report

Thrombotic microangiopathy associated with use of interferon-beta

Teresa Olea1 Department of Nephrology, Hospital Universitario La Paz, Madrid, SpainCorrespondence[email protected]
,
Raquel Díaz-Mancebo1 Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain
,
Maria-Luz Picazo2 Department of Pathology, Hospital Universitario La Paz, Madrid, Spain
,
Jorge Martínez-Ara1 Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain
,
Angel Robles3 Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain
&
Rafael Selgas1 Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain
Pages 97-100 | Published online: 15 Jun 2012

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Julien Mahe, Aurélie Meurette, Anne Moreau, Caroline Vercel & Pascale Jolliet. (2013) Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis. Drug Design, Development and Therapy 7, pages 723-728.
Read now

Articles from other publishers (26)

Maxime Dauvergne, David Buob, Cédric Rafat, Marie-Flore Hennino, Mathilde Lemoine, Vincent Audard, Dominique Chauveau, David Ribes, Emilie Cornec-Le Gall, Eric Daugas, Evangéline Pillebout, Vincent Vuiblet, Jean-Jacques Boffa, Isabelle Brocheriou, David Buob, Laurent Daniel, Laurent Doucet, Arnaud François, Viviane Gnemmi, Anissa Moktefi & Vincent Vuiblet. (2021) Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review. Clinical Kidney Journal 14:12, pages 2563-2572.
Crossref
Reinier Cardentey Sánchez, Amado Díaz Fe, Alejandro Peláez Suarez, Dayme Grass, Teresa Morgado Vega, Armando Sánchez Canal, Dario Siniscalco & María Angeles Robinson Agramonte. (2021) Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis. Drug Development Research 82:5, pages 707-715.
Crossref
Mosè Parisi, Alessia Manni, Francesca Caputo, Maria Trojano & Damiano Paolicelli. (2020) A case report of late‐onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review. Brain and Behavior 11:1.
Crossref
Masoud Mohammad Malekzadeh, Reza Alizadeh, Ziba Aghsaeifard & Mohammad Ali Sahraian. (2020) Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient. Clinical Case Reports 8:6, pages 1061-1064.
Crossref
K. E. Zatolochina, I. I. Snegireva, A. S. Kazakov & V. K. Lepakhin. (2019) Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal Identification. Safety and Risk of Pharmacotherapy 7:2, pages 84-92.
Crossref
Elisa Pereira Pérez, María Dolores Sánchez de la Nieta García, Lucía González López & Francisco Rivera Hernández. (2018) Thrombotic microangiopathy and accelerated hypertension after treatment with interferon beta. Nefrología (English Edition) 38:5, pages 564-565.
Crossref
Elisa Pereira Pérez, María Dolores Sánchez de la Nieta García, Lucía González López & Francisco Rivera Hernández. (2018) Thrombotic microangiopathy and accelerated hypertension after treatment with interferon beta. Nefrología 38:5, pages 564-565.
Crossref
Ajay Kundra, Mirela Andrei & Jen Chin Wang. 2018. Thrombocytopenia. Thrombocytopenia.
Luis Ramos, Carmen Busca & Angel Robles. (2018) Esteatonecrosis aséptica en una paciente con esclerosis múltiple y tratamiento con interferón beta 1b. Medicina Clínica 150:3, pages 122.
Crossref
Luis Ramos, Carmen Busca & Angel Robles. (2018) Aseptic steatonecrosis in a patient with multiple sclerosis with interferon-beta 1b treatment. Medicina Clínica (English Edition) 150:3, pages 122.
Crossref
Ajay Kundra & Jen Chin Wang. (2017) Interferon induced thrombotic microangiopathy (TMA): Analysis and concise review. Critical Reviews in Oncology/Hematology 112, pages 103-112.
Crossref
Haruomi Nishio, Tatsuo Tsukamoto, Takeshi Matsubara, Yoichiro Okada, Ryosuke Takahashi & Motoko Yanagita. (2016) Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report. CEN Case Reports 5:2, pages 179-183.
Crossref
I. Azkune Calle, J.L. Sánchez Menoyo, J. Ruiz Ojeda, J.C. García Moncó & I. Etxeguren Urkixo. (2016) Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: An emerging complication?. Neurología (English Edition) 31:7, pages 508-509.
Crossref
I. Azkune Calle, J.L. Sánchez Menoyo, J. Ruiz Ojeda, J.C. García Moncó & I. Etxeguren Urkixo. (2016) Microangiopatía trombótica asociada a interferón beta-1a subcutáneo: ¿una complicación emergente? Descripción de un caso. Neurología 31:7, pages 508-509.
Crossref
Giulia Antognoli & Lino Cirami. (2018) Thrombotic Microangiopathies: Classification and Differential Diagnosis. Giornale di Tecniche Nefrologiche e Dialitiche 28:3, pages 177-184.
Crossref
Luis F. Quintana & Josep M. Campistol. (2015) Interferón ß, microangiopatía trombótica y síndrome nefrótico. Medicina Clínica 144:2, pages 65-66.
Crossref
Luis F. Quintana & Josep M. Campistol. (2015) Interferon β, nephrotic syndrome and thrombotic microangiopathy. Medicina Clínica (English Edition) 144:2, pages 65-66.
Crossref
Georgina Arrambide. (2014) Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing–remitting multiple sclerosis patients on high-dose interferon beta. Multiple Sclerosis Journal 20:13, pages 1788-1789.
Crossref
Laura Negrotto. (2014) Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. Multiple Sclerosis Journal 20:7, pages 892-893.
Crossref
Marco Capobianco, Giorgina Piccoli, Federica Neve Vigotti, Paola Scapoli, Maria Chiara Deagostini, Carlo Albera, Dario Roccatello & Antonio Bertolotto. (2014) Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. Multiple Sclerosis Journal 20:7, pages 889-891.
Crossref
S Rubin, A Lacraz, V Galantine & P Gosse. (2013) Malignant hypertension and interferon-beta: a case report. Journal of Human Hypertension 28:5, pages 340-341.
Crossref
Reza Vosoughi & James J. Marriott. (2014) Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases. Multiple Sclerosis and Related Disorders 3:3, pages 321-325.
Crossref
Kenar D. Jhaveri, Hitesh H. Shah & Jai Radhakrishnan. (2014) The Authors Reply:. Kidney International 85:1, pages 214.
Crossref
V. X. Tadros & F. Vincent. (2013) Syndromes de microangiopathie thrombotique et oncologieThrombotic microangiopathy syndromes and oncology. Réanimation 22:5, pages 510-520.
Crossref
Elodie Nerrant, Mahmoud Charif, Anne-Sophie Ramay, Hélène Perrochia, Laure Patrier, Nicolas Menjot de Champfleur, Dimitri Renard & Pierre Labauge. (2013) Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patient. Journal of Neurology 260:7, pages 1915-1916.
Crossref
&NA;. (2012) Interferon-β. Reactions Weekly &NA;:1420, pages 30.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.